down arrow

Yili Chuannig Biotechnology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005WX0
CNY
11.26
0.54 (5.04%)

Mar 27

SHE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Yili Chuannig Biotechnology Co., Ltd.

Why is Yili Chuannig Biotechnology Co., Ltd. ?

1
With a fall in Net Sales of -13.76%, the company declared Very Negative results in Sep 25
  • ROCE(HY) Lowest at 12.08%
  • OPERATING PROFIT MARGIN(Q) Lowest at 18.16 %
  • RAW MATERIAL COST(Y) Grown by 28.63% (YoY)
2
Underperformed the market in the last 1 year
  • Even though the market (China Shanghai Composite) has generated returns of 16.01% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -13.32% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Yili Chuannig Biotechnology Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Yili Chuannig Biotechnology Co., Ltd.
-13.32%
-0.38
37.28%
China Shanghai Composite
16.01%
1.07
14.99%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.25%
EBIT Growth (5y)
39.24%
EBIT to Interest (avg)
85.34
Debt to EBITDA (avg)
0.69
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0.57
Tax Ratio
16.66%
Dividend Payout Ratio
42.88%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7,093.73%
ROE (avg)
3,839.06%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
3.10
EV to EBIT
17.70
EV to EBITDA
12.44
EV to Capital Employed
3.06
EV to Sales
5.00
PEG Ratio
NA
Dividend Yield
0.69%
ROCE (Latest)
17.30%
ROE (Latest)
14.01%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-31What is not working for the Company
ROCE(HY)

Lowest at 12.08%

OPERATING PROFIT MARGIN(Q)

Lowest at 18.16 %

RAW MATERIAL COST(Y)

Grown by 28.63% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.55 times

NET SALES(Q)

Fallen at -13.76%

OPERATING PROFIT(Q)

Lowest at CNY 197.42 MM

PRE-TAX PROFIT(Q)

Lowest at CNY 193.38 MM

NET PROFIT(Q)

Lowest at CNY 156.72 MM

EPS(Q)

Lowest at CNY 0.07

Here's what is not working for Yili Chuannig Biotechnology Co., Ltd.

Operating Profit Margin
Lowest at 18.16 % and Fallen
In each period in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
At CNY 193.38 MM has Fallen at -47.47%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 156.72 MM has Fallen at -49.26%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales
Fallen at -13.76%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit
Lowest at CNY 197.42 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Pre-Tax Profit
Lowest at CNY 193.38 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit
Lowest at CNY 156.72 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS
Lowest at CNY 0.07
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio
Lowest at 2.55 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 28.63% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."